| SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients D Geers, MC Shamier, S Bogers, G den Hartog, L Gommers, ... Science immunology 6 (59), eabj1750, 2021 | 413 | 2021 |
| Oxidative stress resulting from Helicobacter pylori infection contributes to gastric carcinogenesis LD Butcher, G den Hartog, PB Ernst, SE Crowe Cellular and molecular gastroenterology and hepatology 3 (3), 316-322, 2017 | 162 | 2017 |
| Successive immunoglobulin and cytokine expression in the small intestine of juvenile chicken A Lammers, WH Wieland, L Kruijt, A Jansma, T Straetemans, A Schots, ... Developmental & Comparative Immunology 34 (12), 1254-1262, 2010 | 113 | 2010 |
| SARS-CoV-2–specific antibody detection for seroepidemiology: a multiplex analysis approach accounting for accurate seroprevalence G den Hartog, RM Schepp, M Kuijer, C GeurtsvanKessel, J van Beek, ... The Journal of infectious diseases 222 (9), 1452-1461, 2020 | 108 | 2020 |
| mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, ... The Lancet Oncology 22 (12), 1681-1691, 2021 | 103 | 2021 |
| The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a … JSF Sanders, FJ Bemelman, AL Messchendorp, CC Baan, D van Baarle, ... Transplantation 106 (4), 821, 2022 | 90 | 2022 |
| Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave ERA Vos, G Den Hartog, RM Schepp, P Kaaijk, J Van Vliet, K Helm, ... J epidemiol community health 75 (6), 489-495, 2021 | 87 | 2021 |
| Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study G den Hartog, ERA Vos, LL van den Hoogen, M van Boven, RM Schepp, ... Clinical Infectious Diseases 73 (12), 2155-2162, 2021 | 76 | 2021 |
| Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia Gerco den Hartog, Ranajoy Chattopadhyay, Amber Ablack, Emily H. Hall ... PLOS Pathogens 12 (1), e1005382, 2016 | 55 | 2016 |
| Berberine and obatoclax inhibit SARS-Cov-2 replication in primary human nasal epithelial cells in vitro FS Varghese, E van Woudenbergh, GJ Overheul, MJ Eleveld, L Kurver, ... Viruses 13 (2), 282, 2021 | 46 | 2021 |
| The mucosal factors retinoic acid and TGF-β1 induce phenotypically and functionally distinct dendritic cell types G Den Hartog, C Van Altena, HFJ Savelkoul, RJ Van Neerven International archives of allergy and immunology 162 (3), 225-236, 2013 | 43 | 2013 |
| Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients S Haggenburg, BI Lissenberg-Witte, RS Van BInnendijk, G Den Hartog, ... Blood advances 6 (5), 1537-1546, 2022 | 40 | 2022 |
| Specificity and effector functions of human RSV-specific IgG from bovine milk G den Hartog, S Jacobino, L Bont, L Cox, LH Ulfman, JHW Leusen, ... PloS one 9 (11), e112047, 2014 | 39 | 2014 |
| Intestinal immune maturation is accompanied by temporal changes in the composition of the microbiota G Den Hartog, G De Vries-Reilingh, AM Wehrmaker, HFJ Savelkoul, ... Beneficial microbes 7 (5), 677-685, 2016 | 30 | 2016 |
| Associations between measures of social distancing and severe acute respiratory syndrome coronavirus 2 seropositivity: A nationwide population-based study in the Netherlands ERA Vos, M van Boven, G den Hartog, JA Backer, D Klinkenberg, ... Clinical Infectious Diseases 73 (12), 2318-2321, 2021 | 29* | 2021 |
| Modulation of Human Immune Responses by Bovine Interleukin-10 G den Hartog, HFJ Savelkoul, R Schoemaker, E Tijhaar, AH Westphal, ... PloS one 6 (3), e18188, 2011 | 28 | 2011 |
| The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV I Tcherniaeva, G den Hartog, G Berbers, F van der Klis Journal of immunological methods 462, 1-8, 2018 | 22 | 2018 |
| Antibody response in immunocompromised patients with hematologic cancers who received a 3-dose mRNA-1273 vaccination schedule for COVID-19 S Haggenburg, Q Hofsink, BI Lissenberg-Witte, AEC Broers, ... JAMA oncology 8 (10), 1477-1483, 2022 | 21 | 2022 |
| Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination? LL van den Hoogen, G Smits, CCE van Hagen, D Wong, ERA Vos, ... Vaccine 40 (15), 2251-2257, 2022 | 19 | 2022 |
| Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y … MB van Ravenhorst, G den Hartog, FRM van der Klis, DM van Rooijen, ... PLOS one 13 (4), e0191261, 2018 | 19 | 2018 |
Corine H. GeurtsvanKesselErasmus MC ViroscienceVerified email at erasmusmc.nl
